glp-1 and anastrozole Sharing some research on medications (weight loss/ anti obesity medications) breast cancer from the San Antonio Breast Cancer Symposium. We are beginning to see some early signals that they GLP-1 Receptor Agonists in Breast

Pellerin, K

Noom's B2B2C business hinges on selling Noom as a benefit into employers and health plans and into pharmaceutical companies (as the support arm of a drug protocol), with the value proposition of 1) reducing healthcare costs overall by solving obesity (21% of healthcare costs associated with being overweight), and 2) improving adherence with long-term drug treatments like GLP-1s

It works by reducing appetite and helping patients achieve significant weight loss

That's the ageing signal the whole NAD-precursor category built its case on

Key Takeaways Semaglutide lowers appetite, but consistent eating at or above maintenance calories will still prevent weight loss

Clinical Science